These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7363635)

  • 1. The effect of newer antiarrhythmic drugs on defibrillation threshold.
    Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA
    Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.
    Kerber RE; Pandian NG; Jensen SR; Constantin L; Kieso RA; Melton J; Hunt M
    J Am Coll Cardiol; 1986 Feb; 7(2):397-405. PubMed ID: 3944361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation.
    Euler DE; Zeman TW; Wallock ME; Scanlon PJ
    Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of quinidine and bretylium on defibrillation energy requirements.
    Dorian P; Fain ES; Davy JM; Winkle RA
    Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs.
    Babbs CF; Yim GK; Whistler SJ; Tacker WA; Geddes LA
    Am Heart J; 1979 Sep; 98(3):345-50. PubMed ID: 157692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
    Koo CC; Allen JD; Pantridge JF
    Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flecainide, encainide, and clofilium on ventricular refractory period extension by transcardiac shocks.
    Sweeney RJ; Gill RM; Steinberg MI; Reid PR
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):50-60. PubMed ID: 8848377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM; Kagan K; Hibser NK
    Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
    Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
    Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?
    Murakawa Y; Yamashita T; Kanese Y; Omata M
    J Am Coll Cardiol; 1997 Mar; 29(3):688-92. PubMed ID: 9060912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibutilide: enhanced defibrillation via plateau sodium current activation.
    Wesley RC; Farkhani F; Morgan D; Zimmerman D
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1269-74. PubMed ID: 8386483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model.
    Dorian P; Wang M; David I; Feindel C
    Circulation; 1991 Feb; 83(2):614-21. PubMed ID: 1991379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation.
    Chow MS; Kluger J; Lawrence R; Fieldman A
    Proc Soc Exp Biol Med; 1986 May; 182(1):63-7. PubMed ID: 3083422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bretylium tosylate on ventricular fibrillation threshold during hypothermia in dogs.
    Bjørnstad H; Mortensen E; Sager G; Refsum H
    Am J Emerg Med; 1994 Jul; 12(4):407-12. PubMed ID: 8031422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bretylium tosylate versus lidocaine in experimental cardiac arrest.
    Vachiery JL; Reuse C; Blecic S; Contempré B; Vincent JL
    Am J Emerg Med; 1990 Nov; 8(6):492-5. PubMed ID: 2222590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial.
    Haynes RE; Chinn TL; Copass MK; Cobb LA
    Am J Cardiol; 1981 Aug; 48(2):353-6. PubMed ID: 7023224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs.
    Babbs CF
    Am Heart J; 1978 Mar; 95(3):331-7. PubMed ID: 622975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrillatory drugs: the case for bretylium tosylate.
    Dronen SC
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):805-7. PubMed ID: 6476547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs.
    Euler DE; Scanlon PJ
    Am J Cardiol; 1985 May; 55(11):1396-401. PubMed ID: 3993577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.